IP Verse

Chiesi Farmaceutici S.p.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Chiesi Farmaceutici S.p.a.

Patent Number:
EP3471805
Title:
Drug Delivery Device With Electronics
Applicant:
NORTON (WATERFORD) LIMITED
Opposition Date:
Feb 14, 2020
Patent Number:
EP2897588
Title:
An Inhalable Medicament
Applicant:
TEVA BRANDED PHARMACEUTICAL PRODUCTS R & D, INC.
Opposition Date:
Feb 6, 2020
Patent Number:
EP3344607
Title:
Solid State Forms Of Selexipag
Applicant:
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Opposition Date:
Feb 6, 2020
Patent Number:
EP1646417
Title:
Inhaler Apparatus
Applicant:
CIPLA (EU) LIMITED
Opposition Date:
Aug 8, 2019
Patent Number:
EP2824174
Title:
Mesenchymal Stem Cells And Uses Therefor
Applicant:
MESOBLAST INTERNATIONAL SÀRL
Opposition Date:
Aug 7, 2019
Patent Number:
EP3071272
Title:
Inhaler Device
Applicant:
CIPLA LIMITED
Opposition Date:
Aug 5, 2019

Latest patents of Chiesi Farmaceutici S.p.a. opposed by its competitors

Patent:
EP2104490
Grant Date:
Jun 26, 2024
Title:
Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation
Oppositions:
1
Patent:
EP3500241
Grant Date:
Oct 4, 2023
Title:
Combination Therapy For Copd
Oppositions:
3
Patent:
EP2890437
Grant Date:
Dec 18, 2019
Title:
Aerosol Inhalation Device
Oppositions:
2
Patent:
EP3384931
Grant Date:
Jul 24, 2019
Title:
Formoterol Superfine Formulation
Oppositions:
1
Patent:
EP3034073
Grant Date:
Jun 12, 2019
Title:
Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma
Oppositions:
3
Patent:
EP3019153
Grant Date:
Sep 5, 2018
Title:
Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation
Oppositions:
1
Patent:
EP2806855
Grant Date:
Jul 11, 2018
Title:
Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation
Oppositions:
1
Patent:
EP2552424
Grant Date:
May 9, 2018
Title:
Process For Preparing Carrier Particles For Dry Powders For Inhalation
Oppositions:
2
Patent:
EP2560611
Grant Date:
Jan 3, 2018
Title:
"Process For Providing Particles With Reduced Electrostatic Charges"
Oppositions:
1
Patent:
EP1294379
Grant Date:
Apr 1, 2009
Title:
A New Use For Deferiprone
Oppositions:
2

Competitors of Chiesi Farmaceutici S.p.a.

LUPIN HEALTHCARE (UK) LIMITED

TEVA UK LIMITED

ZBM PATENTS, S.L.

Want to track Chiesi Farmaceutici S.p.a.?

Feel free to send us a message here and we will get back to you